Guidance for industry : considerations for developmental toxicity studies for preventive and therapeutic vaccines for infectious disease indications.

Other author Center for Biologics Evaluation and Research (U.S.)
Format Electronic
Publication InfoRockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
Descriptioni, 15 pages : digital, PDF file.
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS113605
Subjects

Portion of title Considerations for developmental toxicity studies for preventive and therapeutic vaccines for infectious disease indications
General noteTitle from PDF title page (viewed on June 9, 2009).
General note"February 2006."
Bibliography noteIncludes bibliographical references (p. 12).
Technical detailsMode of access: Internet at the FDA web site. Address as of 6/9/09: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm092267.pdf ; current access is available via PURL.
GPO item number0499-T-02 (online)
Govt. docs number HE 20.4802:D 49/4

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available